Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $47.8200 (-1.85%) ($47.8200 - $47.8200) on Mon. Apr. 5, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.59% (three month average) | RSI | 50 | Latest Price | $47.8200(-1.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1% a day on average for past five trading days. | Weekly Trend | TGTX declines -0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.795% in a week (0% probabilities). VIXM(-41%) VXX(-36%) UUP(-17%) UNG(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.795% (StdDev 3.59%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $46.76(2.27%) | 10 Day Moving Average | $46.98(1.79%) | 20 Day Moving Average | $47.13(1.46%) | To recent high | -11.7% | To recent low | 14.7% | Market Cap | $6.056b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |